Cargando…
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461573/ http://dx.doi.org/10.1038/ijo.2011.203 |
_version_ | 1782245095414693888 |
---|---|
author | Astrup, A Carraro, R Finer, N Harper, A Kunesova, M Lean, M E J Niskanen, L Rasmussen, M F Rissanen, A Rössner, S Savolainen, M J Van Gaal, L |
author_facet | Astrup, A Carraro, R Finer, N Harper, A Kunesova, M Lean, M E J Niskanen, L Rasmussen, M F Rissanen, A Rössner, S Savolainen, M J Van Gaal, L |
author_sort | Astrup, A |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3461573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-34615732012-10-03 Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide Astrup, A Carraro, R Finer, N Harper, A Kunesova, M Lean, M E J Niskanen, L Rasmussen, M F Rissanen, A Rössner, S Savolainen, M J Van Gaal, L Int J Obes (Lond) Corrigendum Nature Publishing Group 2012-06 2012-06-12 /pmc/articles/PMC3461573/ http://dx.doi.org/10.1038/ijo.2011.203 Text en Copyright © 2012 Macmillan Publishers Limited |
spellingShingle | Corrigendum Astrup, A Carraro, R Finer, N Harper, A Kunesova, M Lean, M E J Niskanen, L Rasmussen, M F Rissanen, A Rössner, S Savolainen, M J Van Gaal, L Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide |
title | Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide |
title_full | Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide |
title_fullStr | Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide |
title_full_unstemmed | Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide |
title_short | Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide |
title_sort | safety, tolerability and sustained weight loss over 2 years with the once-daily human glp-1 analogue, liraglutide |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461573/ http://dx.doi.org/10.1038/ijo.2011.203 |
work_keys_str_mv | AT astrupa safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT carraror safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT finern safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT harpera safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT kunesovam safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT leanmej safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT niskanenl safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT rasmussenmf safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT rissanena safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT rossners safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT savolainenmj safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide AT vangaall safetytolerabilityandsustainedweightlossover2yearswiththeoncedailyhumanglp1analogueliraglutide |